Drug Shortage Report for APO-ACETAMINOPHEN

Last updated on 2022-10-20 History
Report ID 166399
Drug Identification Number 00544981
Brand name APO-ACETAMINOPHEN
Common or Proper name ACETAMINOPHEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN
Strength(s) 325MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 U/D
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-04
Estimated end date 2022-10-21
Actual end date 2022-10-19
Shortage status Resolved
Updated date 2022-10-20
Company comments Limited inventory has been released
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-10-20 French Compare
v13 2022-10-20 English Compare
v12 2022-10-07 French Compare
v11 2022-10-07 English Compare
v10 2022-09-23 French Compare
v9 2022-09-23 English Compare
v8 2022-09-16 French Compare
v7 2022-09-16 English Compare
v6 2022-09-06 French Compare
v5 2022-09-06 English Compare
v4 2022-08-26 French Compare
v3 2022-08-26 English Compare
v2 2022-08-09 French Compare
v1 2022-08-09 English Compare

Showing 1 to 14 of 14